Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)

This study has been completed.
Sponsor:
Information provided by:
Mansoura University Children Hospital
ClinicalTrials.gov Identifier:
NCT01306578
First received: March 1, 2011
Last updated: NA
Last verified: February 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
No publications provided by Mansoura University Children Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):